Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Baker

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Rural and Remote Health|March 4, 2019
Teleneurology service provided via tablet technology: 3-year outcomes and physician satisfactionKelly Harper, Megan McLeod, Summer K Brown, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 29, 2008
"Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphonCristiano Quintini, Kenzo Hirose, Koji Hashimoto, et al.
Disability and Rehabilitation|May 25, 2010
Gardening with Huntington's disease clients--creating a programme of winter activitiesJosephine Anne Spring, Mark Baker, Loreane Dauya, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2025
Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stressMaytham Hussein, Simon Crawford, Mark Baker, et al.
Molecules (Basel, Switzerland)|June 10, 2015
Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A VirusVincenzo Carbone, Elena K Schneider, Steve Rockman, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant <i>Klebsiella pneumoniae</i>Maytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
The Lancet. Infectious Diseases|October 9, 2015
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialAung Pyae Phyo, Podjanee Jittamala, François H Nosten, et al.
Anti-Cancer Drugs|March 27, 2002
In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and IIPrakash Mistry, Alistair J Stewart, Wendy Dangerfield, et al.
Computational and Structural Biotechnology Journal|September 21, 2020
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogensMaytham Hussein, Xiaohan Hu, Olivia K A Paulin, et al.
Plos One|November 15, 2014
Suppression of enhanced physiological tremor via stochastic noise: initial observationsCarlos Trenado, Florian Amtage, Frank Huethe, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Rural and Remote Health|March 4, 2019
Teleneurology service provided via tablet technology: 3-year outcomes and physician satisfactionKelly Harper, Megan McLeod, Summer K Brown, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 29, 2008
"Splenic artery steal syndrome" is a misnomer: the cause is portal hyperperfusion, not arterial siphonCristiano Quintini, Kenzo Hirose, Koji Hashimoto, et al.
Disability and Rehabilitation|May 25, 2010
Gardening with Huntington's disease clients--creating a programme of winter activitiesJosephine Anne Spring, Mark Baker, Loreane Dauya, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2025
Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stressMaytham Hussein, Simon Crawford, Mark Baker, et al.
Molecules (Basel, Switzerland)|June 10, 2015
Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A VirusVincenzo Carbone, Elena K Schneider, Steve Rockman, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant <i>Klebsiella pneumoniae</i>Maytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
The Lancet. Infectious Diseases|October 9, 2015
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trialAung Pyae Phyo, Podjanee Jittamala, François H Nosten, et al.
Anti-Cancer Drugs|March 27, 2002
In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase I and IIPrakash Mistry, Alistair J Stewart, Wendy Dangerfield, et al.
Computational and Structural Biotechnology Journal|September 21, 2020
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogensMaytham Hussein, Xiaohan Hu, Olivia K A Paulin, et al.
Plos One|November 15, 2014
Suppression of enhanced physiological tremor via stochastic noise: initial observationsCarlos Trenado, Florian Amtage, Frank Huethe, et al.
Pageof 17